This is another big one. Yuuuuuuuuge, as the former president would say.
Right now, Republicans are running for the hills on the abortion issue but this is different in that it will be decided by the Supreme Court. I don’t know the technicalities of the case but something tells me that Justice John Roberts will look for some way to thread the needle on this and call it a tax or something so he can stay in the good graces of the left.
But there are enough justices to actually do the right thing here. With all the state laws on abortion to be voted on, pro-lifers better get ready for the ultimate cage match. This is win or go home election.
The U.S. Supreme Court has announced that it will review the federal government’s approval of the abortion drug mifepristone, setting up a ruling that could have drastic ramifications for the Biden administration’s ongoing efforts to circumvent state pro-life laws.
In December 2021, the Biden administration’s U.S. Food & Drug Administration (FDA) eliminated its requirement that abortion pills be dispensed in person, allowing pharmacists to instead send them through the mail as long as the recipient has a prescription. Representing a handful of doctors and groups including Alliance for Hippocratic Medicine and the American Association of Pro-Life Obstetricians & Gynecologists, Alliance Defending Freedom (ADF) sued, securing in April a suspension of the policy from a U.S. District Court judge. That same month, the Supreme Court agreed to halt enforcement of that suspension, ensuring abortion pills would remain available nationwide while the case moved through the courts.
In August, the U.S. 5th Circuit Court of Appeals issued a split ruling that sided with the FDA on some aspects of the case, including the abortion drug mifepristone’s original 2000 approval, but ultimately agreed to stay the agency’s more recent actions, meaning abortion pills could no longer be sent through the mail at least for the duration of the case, and that the cutoff point for taking abortion pills was moved back from 10 weeks’ gestation to seven weeks. The ruling also restored other conditions, including in-person office visits, prohibition of prescriptions by non-physicians, and mandatory reporting of non-fatal adverse events.
On Wednesday, the nation’s highest court announced that it will review the August ruling, Axios reports, potentially setting up oral arguments next spring and a decision before the critical 2024 elections, which will determine whether Democrats amass enough power to codify a “right” to abortion in federal law.
